bivalirudin
HIT Guidelines:
Heparin induced thrombocytopenia (HIT) detection and management: See Guideline 916.5002
Bivalirudin dosing in patients with HIT (Heparin induced thrombocytopenia): See Protocol 916.6010
Other Guidelines:
Anticoagluation Management while on ECMO, see Protocol 922.5063
Adult ECMO Bivalirudin Dosing and Monitoring, see Protocol 901.6066
Pediatric Bivalirudin dosing with ECMO: Protocol 916.6004
LH Anticoagulant Management: Policy 900.3207
Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5681
Adult: For reversal, turn off the infusion (short half-life): See Reversal Guideline 900.5010
Pediatric: Reversal of bivalrudin: See Reversal Guideline 900.5866
HIT Guidelines:
Heparin induced thrombocytopenia (HIT) detection and management: See Guideline 916.5002
Bivalirudin dosing in patients with HIT (Heparin induced thrombocytopenia): See Protocol 916.6010
Other Guidelines:
Anticoagluation Management while on ECMO, see Protocol 922.5063
Adult ECMO Bivalirudin Dosing and Monitoring, see Protocol 901.6066
Pediatric Bivalirudin dosing with ECMO: Protocol 916.6004
LH Anticoagulant Management: Policy 900.3207
Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5681
Adult: For reversal, turn off the infusion (short half-life): See Reversal Guideline 900.5010
Pediatric: Reversal of bivalrudin: See Reversal Guideline 900.5866